Inicio Blog

11 diciembre 2018. NOVEDADES Y NUEVAS TENDENCIAS DEL ACCESO VASCULAR: TECNOLOGÍA SANITARIA, REDES Y RELACIONES SOCIALES

0

11 de diciembre de 2018
Inscripción: grumav@grumav.es
Aforo limitado: selección por riguroso orden de inscripción


Centro de Innovación de 3M
C/ Juan Ignacio Luca de Tena, 19-25  28017 Madrid
<M> Suances (L5)
EMT: Parada más cercana: Juan Ignacio Luca de Tena, líneas 104, 114, 146


 

PROGRAMA

10:00 – 10:15 Bienvenida y presentación

10:15- 11:45

MESA 1 LAS TECNOLOGÍAS Y SU INCORPORACIÓN
EN EL ÁMBITO SANITARIO

MODERA:
Dra. Celia García Menéndez
Adjunta Dirección. Hospital Ruber Internacional. Grupo Quirón Salud

10:30- 11:00
El Valor de las Tecnologías en las Organizaciones Sanitarias
Dra. Susana Álvarez Gómez
Médico Inspectora en el Instituto Nacional de la Seguridad Social (INSS). Experta en Gestión Sanitaria

11:00- 11:30
Nuevos modelos y estrategias de compra pública:
10 meses de la nueva Ley de Contratos del Sector Público
D. Manuel Carmona Adrados
Lic. en Ciencias Empresariales. Subdirector Económico
en el Hospital Universitario de Móstoles (Madrid)

11:30- 11:45 PREGUNTAS

11:45 – 12:10 PAUSA CAFÉ

12:10 h -15:00

MESA 2 IMPACTO DE LAS REDES SOCIALES EN EL ACCESO VASCULAR

MODERA:
Jesús de Miguel Ramón.
Business Development Lead. 3M

12:20-12:50
The clinical impact of new technologies in vascular access
Dr. Mauro Pittiruti
Médico cirujano responsable del grupo de Accesos Vasculares. Universitá Cattolica Sacro Cuore. Hospital Universitario A. Gemelli

12:50- 13:20
¿Aprovechas el 2.0?. Uso de las TICs en el ámbito sanitario
D. Pablo Sánchez Ballesteros
Enfermero de la Unidad de Cuidados Intensivos del Consorcio hospitalario Provincial de Castellón

13:20- 13:50
Social media influences in Vascular Acces-does it help or hinder? 
Timothy R. Spencer
Director Principal y Consultor de Global Vascular Access LLC

13:50- 14:20
Transformación digital vs relacional: ¿quién motiva a quién?
Dña. Cintia Lara de Frutos
Consultora independiente de proyectos

14:20- 14:45 PREGUNTAS

14:45- 15:00 CONCLUSIONES Y CIERRE DE LAS JORNADAS

 

[gview file=”http://www.grumav.es/wp-content/uploads/2018/10/diciembre-18-alta-1.pdf”]

Vancomycin-induced red man syndrome presentation in a preterm infant

0

Given the wide use of vancomycin for the treatment of neonatal infections, a good awareness of red man syndrome signs and symptoms in the neonatal population is fundamental to recognize this adverse drug reaction and manage its rare but possible life-threatening complications” Martini et al (2018). Abstract: A male infant born at 32 weeks’ gestation […]

Underreported needlestick injuries among healthcare workers

0

Needlestick injuries (NSIs) among healthcare workers (HCWs) pose an important health challenge and several pieces of evidence show that in many cases HCWs do not report the injury” Joukar et al (2018). Abstract: BACKGROUND: Needlestick injuries (NSIs) among healthcare workers (HCWs) pose an important health challenge and several pieces of evidence show that in many […]

Propofol infusion syndrome is prevented with a prospective screening protocol

0

Propofol infusion syndrome (PIS) is a potentially lethal complication of propofol marked by rhabdomyolysis, metabolic acidosis, and cardiac arrhythmias or collapse. The objective of this study was to determine the effectiveness of a prospective screening protocol to prevent PIS” Schroeppel et al (2018). Abstract: Propofol infusion syndrome (PIS) is a potentially lethal complication of propofol […]

IV Furosemide administration options – continuous infusion versus intermittent boluses

0

The administration of loop diuretics in the management of acute decompensated heart failure (ADHF) whether IV boluses or continuous infusion is still controversial. We intended to evaluate differences between the two administration routes on the thoracic fluid content (TFC) and the renal functions” Ragab et al (2018). Abstract: INTRODUCTION: The administration of loop diuretics in […]

Thromboembolism prophylaxis in high-risk critically ill patients

0

This review discusses observational studies identifying patients at risk of thromboprophylaxis failure and critiques clinical studies evaluating novel thromboprophylaxis strategies in high-risk, critically ill patients with a focus on their limitations” Lewis et al (2018). Abstract: Venous thromboembolism (VTE) is a major health concern associated with significant morbidity and mortality. Critically ill patients are at […]

Vessel health and preservation framework evaluation

0

Vascular access is an important part of many patient care management plans, but has unwanted risks. A working group led by the Infection Prevention Society (IPS) produced a Vessel Health and Preservation (VHP) Framework” Burnett et al (2018). Abstract: BACKGROUND: Vascular access is an important part of many patient care management plans, but has unwanted […]

Extensive overview of central venous access device complications

0

Central venous catheterization is a skill frequently needed in the acute care setting. Patients who have multiple, noncompatible intravenous (IV) medications with limited peripheral access, or who are being given vasoactive or phlebosclerotic agents may not be suitably cared for with a peripheral IV alone” England and Bhimji (2018). Excerpt: Central venous catheterization is a […]

Pancreatitis treatment options explored in this publication

0

Acute triglyceride (TG) lowering therapy is crucial in the early treatment of hypertriglyceridemia (HTG)-induced pancreatitis. Data concerning continuous intravenous infusion of insulin and heparin therapy (IHT) as an equivalent option to plasma exchange (PE) in HTG-induced pancreatitis are limited” Jin et al (2018). Abstract: BACKGROUND: Acute triglyceride (TG) lowering therapy is crucial in the early […]

Recidivism in intravenous drug users with infective endocarditis

0

IVDU patients who underwent cardiac surgery for IE experienced higher risks of perioperative adverse events and inferior mid-term survival compared to non-IVDU, despite being younger and having less comorbidities” Tiako et al (2018). Abstract: BACKGROUND: The proportional incidence of intravenous drug use (IVDU) associated infective endocarditis cases requiring surgery has increased significantly, mirroring the national […]